Mike Matson
Stock Analyst at Needham
(2.43)
# 1,384
Out of 4,502 analysts
358
Total ratings
47.15%
Success rate
-1.92%
Average return
Main Sectors:
32 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NARI Inari Medical | Downgrades: Hold | n/a | $55.39 | - | 5 | Jul 18, 2024 | |
| INMD InMode | Reiterates: Hold | n/a | $17.70 | - | 13 | Jul 11, 2024 | |
| MASI Masimo | Reiterates: Hold | n/a | $109.27 | - | 15 | Jul 9, 2024 | |
| ATRC AtriCure | Reiterates: Buy | $40 | $23.99 | +66.74% | 22 | Jul 8, 2024 | |
| MMSI Merit Medical Systems | Maintains: Buy | $85 → $93 | $87.00 | +6.90% | 16 | Jul 1, 2024 | |
| RMD ResMed | Reiterates: Buy | $236 | $206.20 | +14.45% | 8 | Jun 24, 2024 | |
| PSNL Personalis | Reiterates: Buy | $3.5 | $2.84 | +23.24% | 14 | Jun 21, 2024 | |
| ICUI ICU Medical | Initiates: Hold | n/a | $125.86 | - | 1 | Jun 21, 2024 | |
| BSX Boston Scientific | Reiterates: Buy | $82 | $77.76 | +5.45% | 19 | Jun 18, 2024 | |
| HAE Haemonetics | Upgrades: Buy | $112 | $91.42 | +22.51% | 8 | Jun 12, 2024 | |
| LIVN LivaNova | Reiterates: Buy | $72 | $53.77 | +33.90% | 18 | Jun 6, 2024 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Hold | n/a | $110.55 | - | 18 | May 30, 2024 | |
| SRDX Surmodics | Downgrades: Hold | n/a | $41.81 | - | 16 | May 29, 2024 | |
| MDT Medtronic | Reiterates: Hold | n/a | $79.97 | - | 8 | May 24, 2024 | |
| SYK Stryker | Upgrades: Buy | $392 | $340.42 | +15.15% | 2 | May 22, 2024 | |
| OCX OncoCyte | Reiterates: Buy | $4.25 | $3.21 | +32.40% | 12 | May 16, 2024 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $2.5 | $0.85 | +194.12% | 14 | May 13, 2024 | |
| STE STERIS | Reiterates: Hold | n/a | $231.72 | - | 8 | May 10, 2024 | |
| FNA Paragon 28 | Maintains: Buy | $17 → $14 | $8.30 | +68.67% | 12 | May 9, 2024 | |
| PEN Penumbra | Reiterates: Hold | n/a | $193.22 | - | 6 | May 8, 2024 | |
| VCYT Veracyte | Maintains: Buy | $33 → $27 | $23.42 | +15.29% | 11 | May 8, 2024 | |
| INGN Inogen | Reiterates: Hold | n/a | $9.40 | - | 10 | May 8, 2024 | |
| KIDS OrthoPediatrics | Maintains: Buy | $37 → $42 | $33.86 | +24.04% | 14 | May 7, 2024 | |
| AORT Artivion | Maintains: Buy | $25 → $30 | $28.01 | +7.10% | 11 | May 7, 2024 | |
| AXNX Axonics | Reiterates: Hold | n/a | $68.01 | - | 17 | May 6, 2024 | |
| CNMD CONMED | Reiterates: Buy | $107 | $71.60 | +49.44% | 17 | May 6, 2024 | |
| TFX Teleflex | Reiterates: Hold | n/a | $224.57 | - | 6 | May 3, 2024 | |
| ENOV Enovis | Reiterates: Buy | $82 | $45.91 | +78.61% | 9 | May 3, 2024 | |
| HOLX Hologic | Reiterates: Buy | $90 | $78.34 | +14.88% | 9 | May 3, 2024 | |
| NEO NeoGenomics | Maintains: Buy | $24 → $19 | $15.18 | +25.16% | 17 | Apr 30, 2024 | |
| SIBN SI-BONE | Maintains: Buy | n/a | $16.43 | - | 1 | Mar 9, 2021 | |
| GMED Globus Medical | Maintains: Buy | n/a | $72.66 | - | 1 | Feb 18, 2021 |
Inari Medical
Jul 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $55.39
Upside: -
InMode
Jul 11, 2024
Reiterates: Hold
Price Target: n/a
Current: $17.70
Upside: -
Masimo
Jul 9, 2024
Reiterates: Hold
Price Target: n/a
Current: $109.27
Upside: -
AtriCure
Jul 8, 2024
Reiterates: Buy
Price Target: $40
Current: $23.99
Upside: +66.74%
Merit Medical Systems
Jul 1, 2024
Maintains: Buy
Price Target: $85 → $93
Current: $87.00
Upside: +6.90%
ResMed
Jun 24, 2024
Reiterates: Buy
Price Target: $236
Current: $206.20
Upside: +14.45%
Personalis
Jun 21, 2024
Reiterates: Buy
Price Target: $3.5
Current: $2.84
Upside: +23.24%
ICU Medical
Jun 21, 2024
Initiates: Hold
Price Target: n/a
Current: $125.86
Upside: -
Boston Scientific
Jun 18, 2024
Reiterates: Buy
Price Target: $82
Current: $77.76
Upside: +5.45%
Haemonetics
Jun 12, 2024
Upgrades: Buy
Price Target: $112
Current: $91.42
Upside: +22.51%
LivaNova
Jun 6, 2024
Reiterates: Buy
Price Target: $72
Current: $53.77
Upside: +33.90%
Zimmer Biomet Holdings
May 30, 2024
Reiterates: Hold
Price Target: n/a
Current: $110.55
Upside: -
Surmodics
May 29, 2024
Downgrades: Hold
Price Target: n/a
Current: $41.81
Upside: -
Medtronic
May 24, 2024
Reiterates: Hold
Price Target: n/a
Current: $79.97
Upside: -
Stryker
May 22, 2024
Upgrades: Buy
Price Target: $392
Current: $340.42
Upside: +15.15%
OncoCyte
May 16, 2024
Reiterates: Buy
Price Target: $4.25
Current: $3.21
Upside: +32.40%
Lucid Diagnostics
May 13, 2024
Reiterates: Buy
Price Target: $2.5
Current: $0.85
Upside: +194.12%
STERIS
May 10, 2024
Reiterates: Hold
Price Target: n/a
Current: $231.72
Upside: -
Paragon 28
May 9, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $8.30
Upside: +68.67%
Penumbra
May 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $193.22
Upside: -
Veracyte
May 8, 2024
Maintains: Buy
Price Target: $33 → $27
Current: $23.42
Upside: +15.29%
Inogen
May 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $9.40
Upside: -
OrthoPediatrics
May 7, 2024
Maintains: Buy
Price Target: $37 → $42
Current: $33.86
Upside: +24.04%
Artivion
May 7, 2024
Maintains: Buy
Price Target: $25 → $30
Current: $28.01
Upside: +7.10%
Axonics
May 6, 2024
Reiterates: Hold
Price Target: n/a
Current: $68.01
Upside: -
CONMED
May 6, 2024
Reiterates: Buy
Price Target: $107
Current: $71.60
Upside: +49.44%
Teleflex
May 3, 2024
Reiterates: Hold
Price Target: n/a
Current: $224.57
Upside: -
Enovis
May 3, 2024
Reiterates: Buy
Price Target: $82
Current: $45.91
Upside: +78.61%
Hologic
May 3, 2024
Reiterates: Buy
Price Target: $90
Current: $78.34
Upside: +14.88%
NeoGenomics
Apr 30, 2024
Maintains: Buy
Price Target: $24 → $19
Current: $15.18
Upside: +25.16%
SI-BONE
Mar 9, 2021
Maintains: Buy
Price Target: n/a
Current: $16.43
Upside: -
Globus Medical
Feb 18, 2021
Maintains: Buy
Price Target: n/a
Current: $72.66
Upside: -